meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

Sodium-Glucose Transport Protein (SGLT1) Inhibitors & Type 2 Diabetes

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
Adeghate et al. 2019 Expert Opin. Investig. Drugs 28: 811-820
Review

7/1/2026